| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +100.00% | +4.67% | -0.39% | +5.05% | +5.05% | — |
| 14d | 2 | +100.00% | +4.27% | +0.68% | +3.59% | +3.59% | — |
| 30d | 2 | +0.00% | -10.72% | +3.15% | -13.88% | -13.88% | — |
| 60d | 2 | +0.00% | -22.74% | +4.72% | -27.46% | -27.46% | — |
| 90d | 2 | +0.00% | -23.93% | +6.79% | -30.73% | -30.73% | — |
| 180d | 2 | +0.00% | -32.97% | +11.26% | -44.23% | -44.23% | — |
| 1y | 2 | +0.00% | -67.53% | -6.77% | -60.76% | -60.76% | — |
| 2y | 2 | +0.00% | -72.49% | +4.57% | -77.06% | -77.06% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED |
|---|---|---|---|---|---|---|---|
| TARA PROTARA THERAPEUTICS, INC. | PURCHASE Chief Medical Officer | 4,959 | $10.08 | $50.0K | 9,410 | Jun 10, 2021 | Jun 14, 2021 ↗ |
| TARA PROTARA THERAPEUTICS, INC. | PURCHASE Chief Medical Officer | 4,934 | $10.13 | $50.0K | 14,344 | Jun 10, 2021 | Jun 14, 2021 ↗ |
| TARA PROTARA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 120,000 | — | — | 120,000 | Apr 19, 2021 | Apr 20, 2021 ↗ |